| Head and neck cancer (squamous cell carcinoma) |
5 |
Cisplatin/fluorouracil |
| Esophageal and esophagogastric junction cancer (squamous cell carcinoma & adenocarcinoma) |
4 |
Fluorouracil/oxaliplatin |
| Gastric cancer |
4 |
Fluorouracil/oxaliplatin |
| Colorectal cancer |
5 |
Fluorouracil/oxaliplatin/leucovorin |
| Anal carcinoma |
2 |
Cisplatin/fluorouracil |
| Biliary tract cancers (gallbladder, intrahepatic/extrahepatic cholangiocarcinoma) |
1 |
Gemcitabine/cisplatin |
| Pancreatic adenocarcinoma |
4 |
Gemcitabine/cisplatin |
| Lung cancer |
17 |
Carboplatin/etoposide |
| Osteosarcoma |
2 |
Cisplatin/doxorubicin |
| Soft tissue sarcomas |
7 |
Gemcitabine/docetaxel |
| Breast cancer |
9 |
Doxorubicin |
| Cervical cancer |
3 |
Cisplatin/paclitaxel |
| Uterine cancer |
1 |
Carboplatin/paclitaxel |
| Ovarian cancer (epithelial, fallopian tube & peritoneal) |
2 |
Carboplatin/gemcitabine |
| Vulvar cancer (squamous cell carcinoma) |
1 |
Cisplatin/fluorouracil |
| Prostate cancer |
1 |
Docetaxel |
| Testicular cancer (germ cell tumors) |
3 |
Bleomycin/etoposide/cisplatin |
| Penile cancer |
1 |
Cisplatin/ifosfamide/paclitaxel |
| Bladder (urothelial) cancer |
3 |
Gemcitabine/cisplatin |
| Central nervous system cancers |
2 |
Temozolomide |
| Hodgkin lymphoma |
2 |
Doxorubicin/bleomycin/vinblastine/dacarbazine |
| Non-Hodgkin lymphoma |
3 |
Cyclophosphamide/daunorubicin/vincristine/prednisone |
| Acute lymphoblastic leukemia |
3 |
Daunorubicin/vincristine/prednisone/pegaspargase |
| Chronic lymphocytic leukemia/small lymphocytic leukemia |
1 |
Fludarabine/cyclophosphamide |
| Acute myeloid leukemia |
2 |
Daunorubicin/cytarabine |
